Stephan Menzel

Dr. Stephan Menzel is a Senior Lecturer in the Department of Haematology within the Faculty of Life Sciences & Medicine at King's College London. He is affiliated with the Comprehensive Cancer Centre and School of Cancer & Pharmaceutical Sciences. His research primarily focuses on human genetics, particularly the genetic factors influencing fetal hemoglobin (HbF) persistence in sickle cell disease patients.

Dr. Menzel leads a research program studying approximately 1,000 sickle cell disease patients in collaboration with clinical researchers at King's College London and allied hospitals. His work has identified major genetic modifiers of HbF, which have been confirmed as severity modifiers for both sickle cell disease and beta thalassemia. He maintains international collaborations in Tanzania, Nigeria, and Brazil to study genetic variations across different populations.

His research interests span human genetics, sickle cell disease, fetal hemoglobin regulation, genetic mapping of quantitative traits, disease inheritance patterns, and population-genetic basis of ethnic trait differences. Prior to his work on sickle cell disease, Dr. Menzel conducted research on diabetes at the University of Chicago and Oxford University, where he was involved in discovering genes causing familial forms of type 2 diabetes (MODY).

Analysis of his recent publications shows a consistent focus on genetic modifiers of fetal hemoglobin in sickle cell disease, with increasing emphasis on machine learning approaches for prediction models and expanding international collaborations across diverse populations. His work bridges basic genetic research with clinical applications for improving sickle cell disease management.

• RD Lawrence Research Fellowship, Diabetes UK (1999)

Dr. Menzel has secured multiple research grants including projects funded by the Fetal Medicine Foundation, EPSRC, and MRC. His current research includes understanding the molecular regulation of erythroid cells and identifying novel mechanisms of fetal-hemoglobin induction. He has supervised multiple research projects and students throughout his career. His laboratory work focuses on genetic analysis of sickle cell disease patients and controls to identify genetic factors influencing disease severity and treatment response.